Jerrold F. Rosenbaum
Harvard University
393 Papers
6.1K Citations
Jerrold F. Rosenbaum is an academic researcher from Harvard University. The author has contributed to research in topics: Panic disorder & Anxiety. The author has an hindex of 94, co-authored 392 publications. Previous affiliations of Jerrold F. Rosenbaum include Royal Children's Hospital & Beth Israel Deaconess Medical Center.
Chat about Author
Papers
Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
A. John Rush,Madhukar H. Trivedi,Stephen R. Wisniewski,Andrew A. Nierenberg,Jonathan W. Stewart,Diane Warden,George Niederehe,Michael E. Thase,Philip W. Lavori,Barry D. Lebowitz,Patrick J. McGrath,Jerrold F. Rosenbaum,Harold A. Sackeim,David J. Kupfer,James F. Luther,Maurizio Fava +15 more
TL;DR: The acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial are described and compared.
4.6K
Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design
A. John Rush,Maurizio Fava,Stephen R. Wisniewski,Philip W. Lavori,Madhukar H. Trivedi,Harold A. Sackeim,Michael E. Thase,Andrew A. Nierenberg,Frederic M. Quitkin,T. Michael Kashner,David J. Kupfer,Jerrold F. Rosenbaum,Jonathan E. Alpert,Jonathan W. Stewart,Patrick J. McGrath,Melanie M. Biggs,Kathy Shores-Wilson,Barry D. Lebowitz,Louise Ritz,George Niederehe +19 more
TL;DR: STAR*D as discussed by the authors is a multisite, prospective, randomized, multistep clinical trial of outpatients with nonpsychotic major depressive disorder, which compared various treatment options for those who do not attain a satisfactory response with citalopram, a selective serotonin reuptake inhibitor antidepressant.
1.1K
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
A. John Rush,Helena C. Kraemer,Harold A. Sackeim,Maurizio Fava,Madhukar H. Trivedi,Ellen Frank,Philip T. Ninan,Michael E. Thase,Alan J. Gelenberg,David J. Kupfer,Darrel A. Regier,Jerrold F. Rosenbaum,Oakley S. Ray,Alan F. Schatzberg +13 more
TL;DR: Recommendations suggest that symptom ratings that measure all nine criterion symptom domains to define a major depressive episode are preferred as they provide a more certain ascertainment of remission.
699
Further evidence of association between behavioral inhibition and social anxiety in children.
Joseph Biederman,Dina R. Hirshfeld-Becker,Jerrold F. Rosenbaum,Christine Hérot,Deborah Friedman,Nancy Snidman,Jerome Kagan,Stephen V. Faraone +7 more
TL;DR: This study adds to the growing literature suggesting an association between behavioral inhibition and social anxiety disorder and an inverse relationship between inhibition and disruptive behavior disorders.
683